China Biologic Products, Inc. announced that on March 2, 2015, Mr. Dai Feng resigned from the board of directors of the Company, effective from the same date.
On the same date, the Board appointed Mr. Min Fang, as a director of the Company with immediate effect to fill the vacancy resulting from Mr. Fang's resignation from the Board. Mr. Fang has been a principal at Beijing Warburg Pincus Investment Consulting Company Limited Shanghai Branch since July 2011, and a core member of the China healthcare team. In addition to his role with the Company, Mr. Fang currently serves on the board of several private companies including, among others, EA Inc. and Beijing Amcare Women's and Children's Hospital Co. Ltd.